Celanese Corp (CE) financial statements: income statement, balance sheet and cash flow
Celanese Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Celanese Corp reported revenue of $9.5B (-7.2% year on year) and net income of ($1.2B) (+23.5% year on year).
Income statement
Celanese Corp income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net sales
$9.5B
$10.3B
$10.9B
$9.7B
Cost of sales
($7.6B)
($7.9B)
($8.3B)
($7.3B)
Gross profit
$2.0B
$2.4B
$2.6B
$2.4B
Selling, general and administrative expenses
($899.0M)
($1.0B)
($1.1B)
($824.0M)
Amortization of intangible assets
($164.0M)
($159.0M)
($164.0M)
($62.0M)
Research and development expenses
($125.0M)
($130.0M)
($146.0M)
($112.0M)
Other (charges) gains, net
($1.6B)
($1.7B)
($68.0M)
($8.0M)
Foreign exchange gain (loss), net
$36.0M
$24.0M
$32.0M
($1.0M)
Gain (loss) on disposition of businesses and assets, net
($5.0M)
($14.0M)
$505.0M
$5.0M
Operating profit (loss)
($786.0M)
($697.0M)
$1.7B
$1.4B
Equity in net earnings (loss) of affiliates
$127.0M
$196.0M
$102.0M
$220.0M
Non-operating pension and other postretirement employee benefit (expense) income
$55.0M
($20.0M)
($69.0M)
$17.0M
Interest expense
($701.0M)
($676.0M)
($720.0M)
($405.0M)
Refinancing expense
($68.0M)
$0
($7.0M)
$0
Interest income
$24.0M
$33.0M
$39.0M
$69.0M
Dividend income - equity investments
$122.0M
$128.0M
$126.0M
$133.0M
Other income (expense), net
$7.0M
$40.0M
$25.0M
$9.0M
Earnings (loss) from continuing operations before tax
($1.2B)
($996.0M)
$1.2B
$1.4B
Income tax (provision) benefit
$90.0M
($510.0M)
$790.0M
$489.0M
Earnings (loss) from continuing operations
($1.1B)
($1.5B)
$2.0B
$1.9B
Earnings (loss) from operation of discontinued operations
($24.0M)
($10.0M)
($12.0M)
($9.0M)
Income tax (provision) benefit from discontinued operations
$3.0M
$2.0M
$3.0M
$1.0M
Net earnings (loss)
($1.2B)
($1.5B)
$2.0B
$1.9B
Net (earnings) loss attributable to noncontrolling interests
($14.0M)
($8.0M)
($4.0M)
($8.0M)
Earnings (loss) from continuing operations
($1.1B)
($1.5B)
$2.0B
$1.9B
Earnings (loss) from discontinued operations
($21.0M)
($8.0M)
($9.0M)
($8.0M)
Net earnings (loss) attributable to Celanese Corporation
($1.2B)
($1.5B)
$2.0B
$1.9B
Continuing operations - basic (in dollars per share)
-$10.44
-$13.86
$18.09
$17.55
Discontinued operations - basic (in dollars per share)
-$0.20
-$0.07
-$0.08
-$0.07
Net earnings (loss) - basic (in dollars per share)
-$10.64
-$13.93
$18.01
$17.48
Continuing operations - diluted (in dollars per share)
-$10.44
-$13.86
$18.00
$17.41
Discontinued operations - diluted (in dollars per share)
-$0.20
-$0.07
-$0.08
-$0.07
Net earnings (loss) - diluted (in dollars per share)
-$10.64
-$13.93
$17.92
$17.34
Weighted average shares - basic (in shares)
109.5M
109.3M
108.8M
108.4M
Weighted average shares - diluted (in shares)
109.5M
109.3M
109.4M
109.2M
Celanese Corp income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Net sales
$2.8B
$2.3B
$2.4B
$2.5B
Cost of sales
($2.1B)
($1.9B)
($1.9B)
($2.0B)
Gross profit
$618.0M
$468.0M
$521.0M
$535.0M
Selling, general and administrative expenses
($251.0M)
($226.0M)
($231.0M)
($213.0M)
Amortization of intangible assets
($39.0M)
($40.0M)
($42.0M)
($42.0M)
Research and development expenses
($29.0M)
($28.0M)
($31.0M)
($31.0M)
Other (charges) gains, net
($31.0M)
($20.0M)
($1.5B)
($20.0M)
Foreign exchange gain (loss), net
$10.0M
$12.0M
$2.0M
$6.0M
Gain (loss) on disposition of business and assets, net
($2.0M)
$48.0M
($3.0M)
($2.0M)
Operating profit (loss)
$276.0M
$214.0M
($1.3B)
$233.0M
Equity in net earnings (loss) of affiliates
$11.0M
$35.0M
$39.0M
$29.0M
Non-operating pension and other postretirement employee benefit (expense) income
$5.0M
$5.0M
$2.0M
$1.0M
Interest expense
($186.0M)
($183.0M)
($177.0M)
($177.0M)
Refinancing expense
$0
$0
$0
$0
Interest income
$10.0M
$9.0M
$7.0M
$7.0M
Dividend income - equity investments
$43.0M
$1.0M
$40.0M
$41.0M
Other income (expense), net
($17.0M)
$1.0M
$4.0M
$1.0M
Earnings (loss) from continuing operations before tax
$142.0M
$82.0M
($1.4B)
$135.0M
Income tax (provision) benefit
($11.0M)
($33.0M)
$7.0M
$77.0M
Earnings (loss) from continuing operations
$131.0M
$49.0M
($1.4B)
$212.0M
Earnings (loss) from operation of discontinued operations
($2.0M)
($1.0M)
$0
($10.0M)
Income tax (provision) benefit from discontinued operations
$0
$0
$0
$0
Net earnings (loss)
$129.0M
$48.0M
($1.4B)
$202.0M
Net (earnings) loss attributable to noncontrolling interests
($4.0M)
($4.0M)
($4.0M)
($3.0M)
Net earnings (loss) attributable to Celanese Corporation
$125.0M
$44.0M
($1.4B)
$199.0M
Earnings (loss) from continuing operations
$127.0M
$45.0M
($1.4B)
$209.0M
Earnings (loss) from discontinued operations
($2.0M)
($1.0M)
$0
($10.0M)
Net earnings (loss)
$125.0M
$44.0M
($1.4B)
$199.0M
Continuing operations - basic (in dollars per share)
$1.16
$0.41
-$12.39
$1.91
Discontinued operations - basic (in dollars per share)
-$0.02
-$0.01
$0.00
-$0.09
Net earnings (loss) - basic (in dollars per share)
$1.14
$0.40
-$12.39
$1.82
Continuing operations - diluted (in dollars per share)
$1.15
$0.41
-$12.39
$1.90
Discontinued operations - diluted (in dollars per share)
-$0.02
-$0.01
$0.00
-$0.09
Net earnings (loss) - diluted (in dollars per share)
$1.13
$0.40
-$12.39
$1.81
Weighted average shares - basic (in shares)
109.8M
109.7M
109.6M
109.5M
Weighted average shares - diluted (in shares)
110.2M
110.0M
109.6M
109.7M
Balance sheet
Celanese Corp balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$1.3B
$962.0M
$1.8B
$1.5B
Trade receivables - third party and affiliates, net
$922.0M
$1.1B
$1.2B
$1.4B
Non-trade receivables, net
$545.0M
$493.0M
$541.0M
$675.0M
Inventories
$2.2B
$2.3B
$2.4B
$2.8B
Assets held for sale
$492.0M
—
—
—
Other assets
$251.0M
$285.0M
$272.0M
$241.0M
Total current assets
$5.7B
$5.1B
$6.2B
$6.6B
Investments in affiliates
$1.3B
$1.2B
$1.2B
$1.1B
Property, plant and equipment, net
$5.1B
$5.3B
$5.6B
$5.6B
Operating lease right-of-use assets
$359.0M
$388.0M
$422.0M
$413.0M
Deferred income taxes
$1.4B
$1.3B
$1.7B
$808.0M
Other assets
$601.0M
$555.0M
$524.0M
$547.0M
Goodwill
$4.2B
$5.4B
$7.0B
$7.1B
Intangible assets, net
$3.2B
$3.6B
$4.0B
$4.1B
Total assets
$21.7B
$22.9B
$26.6B
$26.3B
Short-term borrowings and current installments of long-term debt - third party and affiliates
$1.2B
$1.5B
$1.4B
$1.3B
Trade payables - third party and affiliates
$1.3B
$1.2B
$1.5B
$1.5B
Liabilities held for sale
$75.0M
—
—
—
Other liabilities
$1.0B
$1.1B
$1.2B
$1.2B
Income taxes payable
$76.0M
$4.0M
$25.0M
$43.0M
Total current liabilities
$3.7B
$3.9B
$4.1B
$4.1B
Long-term debt, net of unamortized deferred financing costs
$11.4B
$11.1B
$12.3B
$13.4B
Deferred income taxes
$512.0M
$933.0M
$999.0M
$1.2B
Uncertain tax positions
$208.0M
$286.0M
$300.0M
$322.0M
Benefit obligations
$344.0M
$396.0M
$457.0M
$411.0M
Operating lease liabilities
$265.0M
$294.0M
$325.0M
$364.0M
Other liabilities
$817.0M
$408.0M
$591.0M
$387.0M
Common stock, $0.0001 par value, 400,000,000 shares authorized (2025: 170,918,221 and 2024: 170,827,196 issued)
0
0
0
0
Treasury stock, at cost
($5.5B)
($5.5B)
($5.5B)
($5.5B)
Additional paid-in capital
$431.0M
$409.0M
$394.0M
$372.0M
Retained earnings
$9.9B
$11.1B
$12.9B
$11.3B
Accumulated other comprehensive income (loss), net
($776.0M)
($848.0M)
($744.0M)
($518.0M)
Total Celanese Corporation shareholders' equity
$4.0B
$5.2B
$7.1B
$5.6B
Noncontrolling interests
$423.0M
$434.0M
$461.0M
$468.0M
Total equity
$4.5B
$5.6B
$7.6B
$6.1B
Total liabilities and equity
$21.7B
$22.9B
$26.6B
$26.3B
Celanese Corp balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$1.4B
$1.8B
$1.4B
$1.2B
Trade receivables - third party and affiliates
$1.3B
$1.1B
$1.0B
$1.2B
Non-trade receivables, net
$581.0M
$583.0M
$657.0M
$703.0M
Inventories
$2.3B
$2.3B
$2.2B
$2.3B
Assets held for sale
$0
$0
$471.0M
—
Other assets
$257.0M
$247.0M
$271.0M
$295.0M
Total current assets
$5.8B
$6.0B
$6.1B
$5.7B
Investments in affiliates
$1.2B
$1.2B
$1.3B
$1.3B
Property, plant and equipment, net
$4.8B
$4.9B
$5.2B
$5.3B
Operating lease right-of-use assets
$417.0M
$376.0M
$372.0M
$388.0M
Deferred income taxes
$1.3B
$1.3B
$1.3B
$1.3B
Other assets
$605.0M
$608.0M
$546.0M
$525.0M
Goodwill
$4.2B
$4.2B
$4.2B
$5.5B
Intangible assets, net
$3.1B
$3.1B
$3.2B
$3.8B
Total assets
$21.4B
$21.7B
$22.2B
$23.7B
Short-term borrowings and current installments of long-term debt - third party and affiliates
$1.3B
$1.7B
$1.2B
$252.0M
Trade payables - third party and affiliates
$1.5B
$1.4B
$1.2B
$1.3B
Liabilities held for sale
$0
$0
$62.0M
—
Other liabilities
$1.1B
$1.0B
$1.2B
$1.1B
Income taxes payable
$104.0M
$94.0M
$47.0M
$95.0M
Total current liabilities
$4.0B
$4.3B
$3.7B
$2.8B
Long-term debt, net of unamortized deferred financing costs
$10.7B
$10.8B
$11.7B
$12.7B
Deferred income taxes
$458.0M
$512.0M
$669.0M
$704.0M
Uncertain tax positions
$211.0M
$225.0M
$230.0M
$226.0M
Benefit obligations
$321.0M
$332.0M
$402.0M
$411.0M
Operating lease liabilities
$317.0M
$275.0M
$278.0M
$295.0M
Other liabilities
$811.0M
$777.0M
$829.0M
$917.0M
Common stock, $0.0001 par value, 400,000,000 shares authorized (2026: 171,036,104 issued and 2025: 170,918,221 issued)
0
0
0
0
Treasury stock, at cost
($5.5B)
($5.5B)
($5.5B)
($5.5B)
Additional paid-in capital
$450.0M
$439.0M
$425.0M
$419.0M
Retained earnings
$10.0B
$9.9B
$9.9B
$11.2B
Accumulated other comprehensive income (loss), net
($842.0M)
($811.0M)
($849.0M)
($903.0M)
Total Celanese Corporation shareholders' equity
$4.2B
$4.1B
$4.0B
$5.3B
Noncontrolling interests
$421.0M
$422.0M
$425.0M
$428.0M
Total equity
$4.6B
$4.5B
$4.4B
$5.7B
Total liabilities and equity
$21.4B
$21.7B
$22.2B
$23.7B
Cash flow statement
Celanese Corp cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net earnings (loss)
($1.2B)
($1.5B)
$2.0B
$1.9B
Asset impairment losses
$1.5B
$1.6B
$15.0M
$14.0M
Depreciation, amortization and accretion
$786.0M
$823.0M
$739.0M
$478.0M
Pension and postretirement net periodic benefit cost
$8.0M
$6.0M
$13.0M
($85.0M)
Pension and postretirement contributions
($54.0M)
($54.0M)
($49.0M)
($48.0M)
Actuarial (gain) loss on pension and postretirement plans
($45.0M)
$37.0M
$66.0M
$81.0M
Pension curtailments and settlements, net
($3.0M)
($9.0M)
$1.0M
$0
Deferred income taxes, net
($278.0M)
$216.0M
($967.0M)
($835.0M)
(Gain) loss on disposition of businesses and assets, net
$5.0M
$13.0M
($501.0M)
($8.0M)
Stock-based compensation
$24.0M
$32.0M
$40.0M
$60.0M
Undistributed earnings in unconsolidated affiliates
$13.0M
($33.0M)
$55.0M
($3.0M)
Other, net
$81.0M
$19.0M
$9.0M
$11.0M
Operating cash provided by (used in) discontinued operations
$12.0M
($5.0M)
($2.0M)
($28.0M)
Trade receivables - third party and affiliates, net
$213.0M
$92.0M
$105.0M
$218.0M
Inventories
$154.0M
$11.0M
$398.0M
($253.0M)
Other assets
$167.0M
($10.0M)
$277.0M
($13.0M)
Trade payables - third party and affiliates
$26.0M
($234.0M)
$20.0M
($84.0M)
Other liabilities
($325.0M)
($63.0M)
($284.0M)
$412.0M
Net cash provided by (used in) operating activities
$1.1B
$966.0M
$1.9B
$1.8B
Capital expenditures on property, plant and equipment
($343.0M)
($435.0M)
($568.0M)
($543.0M)
Acquisitions, net of cash acquired
$0
$0
$52.0M
($10.6B)
Proceeds from sale of businesses and assets, net
$21.0M
$0
$480.0M
$48.0M
Settlement of cross-currency swap agreement
$0
$17.0M
—
—
Other, net
($27.0M)
($52.0M)
($98.0M)
($57.0M)
Net cash provided by (used in) investing activities
($349.0M)
($470.0M)
($134.0M)
($11.1B)
Net change in short-term borrowings with maturities of 3 months or less
$8.0M
$15.0M
($278.0M)
$36.0M
Proceeds from short-term borrowings
$606.0M
$160.0M
$452.0M
$500.0M
Repayments of short-term borrowings
($637.0M)
($418.0M)
($603.0M)
$0
Proceeds from long-term debt
$4.4B
$328.0M
$3.0B
$10.8B
Repayments of long-term debt
($4.7B)
($1.0B)
($3.7B)
($526.0M)
Common stock dividends
($13.0M)
($307.0M)
($305.0M)
($297.0M)
Distributions/dividends to noncontrolling interests
($30.0M)
($33.0M)
($11.0M)
($13.0M)
Other, net
($147.0M)
($26.0M)
($52.0M)
($99.0M)
Net cash provided by (used in) financing activities
($513.0M)
($1.3B)
($1.5B)
$10.3B
Exchange rate effects on cash and cash equivalents
$17.0M
($26.0M)
($12.0M)
$4.0M
Net increase (decrease) in cash and cash equivalents
$301.0M
($843.0M)
$297.0M
$972.0M
Cash and cash equivalents as of beginning of period
$962.0M
$1.8B
$1.5B
$536.0M
Cash and cash equivalents as of end of period
$1.3B
$962.0M
$1.8B
$1.5B
Celanese Corp cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net earnings (loss)
$177.0M
$48.0M
($1.2B)
$185.0M
Depreciation, amortization and accretion
$457.0M
$208.0M
$585.0M
$384.0M
Pension and postretirement net periodic benefit cost
($5.0M)
($2.0M)
$5.0M
$4.0M
Pension and postretirement contributions
($26.0M)
($13.0M)
($38.0M)
($27.0M)
Deferred income taxes, net
($70.0M)
($18.0M)
($118.0M)
($44.0M)
(Gain) loss on disposition of businesses and assets, net
$47.0M
$48.0M
($3.0M)
$2.0M
Stock-based compensation
$18.0M
$8.0M
$19.0M
$12.0M
Undistributed earnings in unconsolidated affiliates
$24.0M
$18.0M
$3.0M
$2.0M
Operating cash provided by (used in) discontinued operations
($13.0M)
($13.0M)
$6.0M
$8.0M
Trade receivables - third party and affiliates, net
($399.0M)
($203.0M)
$96.0M
($31.0M)
Inventories
($103.0M)
($80.0M)
$158.0M
$115.0M
Other assets
($58.0M)
($18.0M)
$131.0M
$99.0M
Trade payables - third party and affiliates
$228.0M
$187.0M
$3.0M
$38.0M
Other liabilities
$101.0M
$5.0M
($312.0M)
($336.0M)
Net cash provided by (used in) operating activities
$285.0M
$76.0M
$894.0M
$447.0M
Capital expenditures on property, plant and equipment
($128.0M)
($66.0M)
($259.0M)
($195.0M)
Proceeds from sale of businesses and assets, net
($493.0M)
($493.0M)
($7.0M)
($7.0M)
Other, net
$1.0M
($3.0M)
$40.0M
$40.0M
Net cash provided by (used in) investing activities
$366.0M
$425.0M
($245.0M)
($186.0M)
Net change in short-term borrowings with maturities of 3 months or less
$11.0M
$8.0M
$3.0M
$1.0M
Proceeds from short-term borrowings
$29.0M
$0
$606.0M
$589.0M
Repayments of short-term borrowings
($43.0M)
($43.0M)
($555.0M)
($555.0M)
Proceeds from long-term debt
$96.0M
$58.0M
$2.9B
$2.8B
Repayments of long-term debt
($621.0M)
($15.0M)
($3.1B)
($2.8B)
Common stock dividends
($6.0M)
($3.0M)
($9.0M)
($6.0M)
Distributions/dividends to noncontrolling interests
($14.0M)
($7.0M)
($22.0M)
($14.0M)
Other, net
($1.0M)
($2.0M)
$7.0M
$2.0M
Net cash provided by (used in) financing activities
($549.0M)
($3.0M)
($189.0M)
($71.0M)
Exchange rate effects on cash and cash equivalents
($1.0M)
($3.0M)
$18.0M
$21.0M
Net increase (decrease) in cash and cash equivalents
$101.0M
$495.0M
$478.0M
$211.0M
Cash and cash equivalents as of beginning of period